Please log in to view this page
Username
Password
IMPAACT 2010 is a Phase III, three-arm, randomized, open-label study of HIV-1-infected pregnant women initiating either a...
ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...
The A5322 protocol is a long-term observational study, with a planned series of analyses of data to be collected from an...
HPTN 083 is a study being done to evaluate the efficacy of the long-acting injectable agent, cabotegravir (CAB LA), for...
The purpose of this study is to develop and assess the efficacy of an integrated strategy that includes feasible and scalable...
